Altered expression of mir-21 and PTEN in human laryngeal and hypopharyngeal squamous cell carcinomas

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 10, 2011, Pages 2653-2657

  Liu, Jun ^a,b   Lei, Da Peng ^a,b   Jin, Tong ^a,b   Zhao, Xue Ning ^a,b   Li, Guojun ^c   Pan, Xin Liang ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

21; China; Hypopharyngeal SCC; Laryngeal SCC; Microrna; PTEN

Indexed keywords

EID: 84863248449     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bartel DP (2004).MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97.
2. Calin GA, Dumitru CD, Shimizu M, et al (2002). Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A, 99, 15524-9.
3. Chan, JA, Krichevsky, AM, Kosik, KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res, 65, 6029-33.
4. Chen CZ (2005). MicroRNAs as oncogenes and tumor suppressors. The New England J of Medicine, 353, 1768-71
5. Cho WC (2007). OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer, 6, 60.
6. Forastiere AA, Trotti A, Pfister DG, Grandis JR (2006). Head and neck cancer: recent advances and new standards of care. J Clin Oncol, 24, 2603-5.
7. Frankel LB, Christoffersen NR, Jacobsen A, et al (2008). Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem, 283, 1026-33.
8. Gleich LL, Salamone FN (2002). Molecular genetics of head and neck cancer. Cancer Control J of the Moffitt Cancer Center, 9, 369-78.
9. Gregory RI, Shiekhattar R (2005). MicroRNA biogenesis and cancer. Cancer Research, 65, 3509-12.
10. Guney K, Ozbilim G, Derin AT, Cetin S (2007). Expression of PTEN protein in patients with laryngeal squamous cell carcinoma. Auris, Nasus, Larynx, 34, 481-6.
11. Habbe N, Koorstra JB, Mendell JT, et al (2009). MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther, 8, 340-6.
12. He L, Thomson JM, Hemann MT, et al (2005). A microRNA polycistron as a potential human oncogene. Nature, 435, 828-33.
13. Hui AB, Lenarduzzi M, Krushel T, et al (2010). Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res, 16, 1129-39
14. Jemal A, Murray T, Ward E, et al (2005). Cancer statistics, 2005. CA Cancer J Clin, 55, 10-30.
15. Jovanovic M, Hengartner MO (2006). miRNAs and apoptosis: RNAs to die for. Oncogene, 25, 6176-87.
16. Kimura S, Naganuma S, Susuki D, et al (2010). Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol Rep, 23, 1625-33.
17. Li J, Huang H, Sun L, et al (2009). MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res, 15, 3998-4008.
18. Liu X, Chen Z, Yu J, et al (2009). MicroRNA profiling and head and neck cancer. Comp Funct Genomics, 837514.
19. Ma L, Weinberg RA (2008). MicroRNAs in malignant progression. Cell Cycle, 7, 570-2.
20. Meng F, Henson R, Wehbe-Janek H, et al (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133, 647-58.
21. Mriouah J, Boura C, Pinel S, et al (2010). Cellular response to cetuximab in PTEN-silenced head and neck squamous cell carcinoma cell line. Int J Oncol, 37, 1555-63.
22. Pattje WJ, Schuuring E, Mastik MF, et al (2010). The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer. Br J Cancer, 102, 1778-85.
23. Poy MN, Eliasson L, Krutzfeldt J, et al (2004). A pancreatic islet-specific microRNA regulates insulin secretion. Nature, 432, 226-30.
24. Schetter AJ, Leung SY, Sohn JJ, et al (2008). MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-36
25. Tamura M, Gu J, Matsumoto K, et al (1998). Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science (New York, N Y), 280, 1614-7.
26. Takamizawa J, Konishi H, Yanagisawa K, et al (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res, 64, 3753-6.
27. Tran N, McLean T, Zhang X, et al (2007). MicroRNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun, 358, 12-7.
28. Wu W, Sun M, Zou G.M, Chen J (2007). MicroRNA and cancer: Current status and prospective. Int J Cancer, 120, 953-60.
29. Yan LX, Huang XF, Shao Q, et al (2008). MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA, 14, 2348-60.